abstract |
The present invention relates to an anticancer agent comprising a microRNA as an active ingredient, more specifically, an anticancer agent comprising a miRNA, an anticancer agent comprising a miRNA, and comprising an anticancer agent, miRNA, which inhibits the activity of p85α or Cdc42, It relates to an anticancer agent characterized in that it promotes activity and a method for producing the same. |